1. Accueil
  2. Investir
  3. Actions
  4. L'Europe
  5. EU
  6. Argen X SE (ARGX)
  7. Actualités

ARGX

Actualités Argen X

Les meilleurs offres pour accéder les cours en temps réel en illimité
Mini
Abonnement Mensuel
Seulement
10,55 €
Complet Euronext
Abonnement Mensuel
Seulement
26,39 €
Intégral
Abonnement Mensuel
Seulement
19,79 €
Prix hors taxes
Nom Action Symbole Action Marché Type
Argen X SE ARGX Euronext Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
1,20 0,4% 301,50 10:35:08
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
300,00 299,00 302,60 300,30
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
10/5/202223:30GLOBEargenx announces results of Annual General Meeting of..
05/5/202207:00GLOBEargenx Reports First Quarter 2022 Financial Results and..
04/5/202207:00GLOBEargenx to Present at BofA Securities 2022 Healthcare..
28/4/202207:00GLOBEargenx to Report First Quarter 2022 Financial Results and..
05/4/202207:00GLOBEargenx Presents Interim Results from ADAPT+ Open-Label..
29/3/202223:00GLOBEargenx announces full exercise of underwriters’ option to..
29/3/202222:30GLOBEargenx announces Annual General Meeting of Shareholders on..
28/3/202222:30GLOBEargenx announces closing of global offering
24/3/202202:00GLOBEargenx raises $700 million in gross proceeds in a global..
22/3/202221:15GLOBEargenx announces launch of proposed global offering
03/3/202207:00GLOBEargenx Reports Full Year 2021 Financial Results and Provides..
28/2/202207:00GLOBEargenx to Present at the 42nd Annual Cowen Health Care..
24/2/202207:00GLOBEargenx to Report Full Year 2021 Financial Results and Fourth..
10/2/202207:00GLOBEargenx to Present at the 11th Annual SVB Leerink Global..
03/1/202207:00GLOBEargenx to Present at 40th Annual J.P. Morgan Healthcare..
18/12/202100:09GLOBEZai Lab Partner argenx Announces U.S. Food and Drug..
10/11/202107:00GLOBEargenx to Present at Upcoming Investor Conferences
28/10/202107:00GLOBEargenx Reports Third Quarter 2021 Financial Results and..
21/10/202107:00GLOBEargenx to Report Third Quarter 2021 Financial Results and..
08/10/202107:00GLOBEargenx to Highlight Potential First-in-Class FcRn Antagonist..
03/9/202107:00GLOBEargenx to Present at Upcoming Investor Conferences
25/8/202107:00GLOBEargenx Announces Validation of European Marketing..
04/8/202107:00GLOBEargenx to Present at 2021 Wedbush PacGrow Virtual Healthcare..
29/7/202107:00GLOBEargenx Reports Half Year 2021 Financial Results and Provides..
22/7/202107:00GLOBEargenx to Report Half Year 2021 Financial Results and Second..
14/7/202107:00GLOBEargenx to Host Virtual R&D Day on July 20, 2021
17/6/202100:30GLOBEargenx announces publication of Phase 3 ADAPT trial results..
07/6/202107:00GLOBEargenx to regain global rights to cusatuzumab
01/6/202110:01GLOBEargenx Appoints Karl Gubitz as Chief Financial Officer
01/6/202107:00GLOBEargenx to Present at Upcoming Investor Conferences
Dernières Valeurs Consultées
EU
ARGX
Argen X
Inscrivez-vous aujourd'hui pour consulter ce titre en streaming sur le Moniteur ADVFN. Vous pourrez ajouter et visualiser jusqu'à 110 des vos actions préférée et c'est complètement gratuit..

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

P: V: D:20220518 08:50:13